Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,637.00-0.40%ETH$2,280.71+0.75%GOLD$3,910.10+0.29%OIL$99.56-4.38%
Smart Investors Daily
SID Premium
EL

NASDAQ · ELAB

PMGC Holdings Inc.

Healthcare · Biotechnology

$2.60

Down-$0.04 (-1.52%)

Updated Nov 2, 2026, 12:21 PM

SID Score

3.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.71M
P/E ratio
-0.52
Dividend yield
0.00%
52-week range
$0.84 – $147.12
Volume
7.49K
Avg. volume
556.88K

Price performance · ELAB

ELAB price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

ELAB closed at $2.60 after 20 trading sessions, down 20.49% for the selected period.

Last close
$2.60
Period change
-20.49%
Period low
$2.57
Period high
$3.27
Daily close
View OHLC price history
ELAB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$2.64$2.70$2.51$2.607.49K
Oct 29, 2026$2.57$2.70$2.52$2.646.7K
Oct 28, 2026$2.745$2.7793$2.56$2.577.37K
Oct 27, 2026$2.79$2.86$2.5195$2.589.11K
Oct 26, 2026$2.71$2.755$2.585$2.6117.17K
Oct 23, 2026$2.76$2.76$2.7057$2.70571.37K
Oct 22, 2026$2.695$2.765$2.62$2.665.18K
Oct 21, 2026$2.7992$2.81$2.758$2.783.44K
Oct 20, 2026$2.87$2.87$2.75$2.814.8K
Oct 19, 2026$2.81$2.89$2.80$2.834.85K
Oct 16, 2026$3.00$3.0299$2.6833$2.7712.55K
Oct 15, 2026$2.94$3.06$2.785$3.0415.83K
Oct 14, 2026$3.01$3.07$2.96$2.9711.19K
Oct 13, 2026$3.05$3.06$2.85$2.9613.69K
Oct 12, 2026$3.06$3.14$3.00$3.058.64K
Oct 9, 2026$3.12$3.12$3.07$3.084.05K
Oct 8, 2026$3.24$3.3351$3.06$3.12516.56K
Oct 7, 2026$3.19$3.39$3.12$3.1419.94K
Oct 6, 2026$3.23$3.30$3.08$3.2714.66K
Oct 5, 2026$3.30$3.36$3.0601$3.2741.54K

Latest ELAB news

The latest Smart Investors Daily articles mentioning ELAB.

Stock researchCompany · Overview

ELAB research

Overview

Company profile and research snapshot.

Company profile

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 8, 2026

PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update

Adoption of NorthStrive® brand marks and DBA registration establishes a unified identify across PMGC’s public holding company structure, with a formal legal name change expected within six monthsNEWPORT BEACH, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“NorthStrive Holdings” or the “Company”) announces that it has registered a doing-business-as (DBA) name as NorthStrive Holdings, Inc. and entered into a Trademark License Agreement with NorthStrive Companies Inc.

Yahoo · Oct 1, 2026

PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy

PMGC's first sponsored SPAC adds a public-market acquisition vehicle to the holding company, targeting aerospace and defense, industrial technology, and critical supply chain manufacturersSponsor position of approximately 2.7 million shares, or roughly 21.4% of NorthStrive Acquisition Corp I.'s Class A shares on an as-converted basis, aligns PMGC with value created through a future business combination NEWPORT BEACH, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“P

Yahoo · Sep 29, 2026

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

Engagement of a leading global contract research organization strengthens the analytical foundation supporting EL-22 and EL-32 as the programs advance toward an IND-enabling development frameworkBuilds on NorthStrive Biosciences’ expanding manufacturing and characterization capabilities behind its engineered probiotic platform targeting muscle preservation, including for patients on GLP-1 weight loss treatments NEWPORT BEACH, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq:

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By